In our study, we observed that the incidence of sLAE was higher in ESUS patients than in patients with noncardioembolic strokes, while there was no difference in the proportion of elevated serum NT‐proBNP between ESUS patients and patients with noncardioembolic strokes. The gene discussed is NPPB; the disease is Stroke.